Dabigatran Users With Non-Valvular Atrial Fibrillation in the Us: A Characterization of Dabigatran Initiators and Switchers
Shash, D, Schnee, J, Schneider, G, Schoof, N, Zint, K, Clemens, A, Bartels, D.B
Published in Value in health (01.11.2014)
Published in Value in health (01.11.2014)
Get full text
Journal Article
PM198 Antithrombotic Treatment in Relation to Age and Stroke Risk in Patients With Newly Diagnosed Atrial Fibrillation (Gloria-AF Phase II)
Halperin, J, Huisman, M, Diener, H.-C, Dubner, S, Ma, C, Rothman, K, Healey, J, Zint, K, Teutsch, C, Lip, G
Published in Global heart (01.06.2016)
Published in Global heart (01.06.2016)
Get full text
Journal Article
P286Safety and effectiveness of dabigatran relative to warfarin in routine care: final results from a long-term monitoring program
Gopalakrishnan, C, Huybrechts, K F, Ortiz, A S, Zint, K, Gurusamy, V K, Bartels, D B, Schneeweiss, S
Published in European heart journal (01.08.2018)
Published in European heart journal (01.08.2018)
Get full text
Journal Article
P3849Baseline profile of patients treated for acute venous thromboembolism in routine clinical practice according to age and renal function in the RE-COVERY DVT/PE global cohort study
Ageno, W, Casella, I B, Han, C K, Schellong, S, Schulman, S, Singer, D E, Desch, M, Tang, W, Voccia, I, Zint, K, Goldhaber, S Z
Published in European heart journal (01.10.2019)
Published in European heart journal (01.10.2019)
Get full text
Journal Article
P3848Baseline profile of patients treated for acute venous thromboembolism (VTE) in routine clinical practice according to VTE location in the RE-COVERY DVT/PE global cohort study
Schellong, S, Ageno, W, Casella, I B, Han, C K, Schulman, S, Singer, D E, Desch, M, Tang, W, Voccia, I, Zint, K, Goldhaber, S Z
Published in European heart journal (01.10.2019)
Published in European heart journal (01.10.2019)
Get full text
Journal Article
P4783Treatment persistence of patients with atrial fibrillation on VKA or NOAC: Data from GLORIA-AF Phase III 1-year interim analysis
Lip, G Y H, Diener, H.-C, Dubner, S J, Halperin, J L, Rothman, K J, Ma, C.-S, Lu, S, Paquette, M, Riou Franca, L, Zint, K, Teutsch, C, Huisman, M V
Published in European heart journal (01.10.2019)
Published in European heart journal (01.10.2019)
Get full text
Journal Article
P4600Prescribing of dabigatran etexilate in accordance with the European label for stroke prevention in atrial fibrillation: Findings from the GLORIA-AF Registry
Lip, G.Y.H., Teusch, C., Huisman, M.V., Diener, H.C., Dubner, S.J., Ma, C.S., Rothman, K.J., Elsaesser, A., Paquette, M., Zint, K., Bartels, D., Halperin, J.L.
Published in European heart journal (01.08.2017)
Published in European heart journal (01.08.2017)
Get full text
Journal Article
P4799When are atrial fibrillation patients at risk to discontinue anticoagulation treatment? Results from the GLORIA-AF Registry
Paquette, M, Huisman, M V, Lip, G Y H, Diener, H.-C, Dubner, S J, Halperin, J L, Rothman, K J, Ma, C S, Lu, S, Riou Franca, L, Teutsch, C, Zint, K, Nieuwlaat, R
Published in European heart journal (01.08.2018)
Published in European heart journal (01.08.2018)
Get full text
Journal Article
P3862A prospective global registry on oral antithrombotic treatment in patients with atrial fibrillation: GLORIA-AF Phase III baseline characteristics
Huisman, M V, Diener, H.-C, Dubner, S J, Halperin, J L, Rothman, K J, Ma, C.-S, Lu, S, Paquette, M, Teutsch, C, Franca, L R, Zint, K, Lip, G Y H
Published in European heart journal (01.08.2018)
Published in European heart journal (01.08.2018)
Get full text
Journal Article
P2896Two-year outcomes of dabigatran etexilate in patients with atrial fibrillation with and without a history of coronary artery disease: data from GLORIA-AF
Halperin, J L, Teutsch, C, Huisman, M V, Diener, H.-C, Rothman, K J, Ma, C S, Dubner, S J, Zint, K, Riou Franca, L, Paquette, M, Lip, G Y H
Published in European heart journal (01.08.2018)
Published in European heart journal (01.08.2018)
Get full text
Journal Article
P5140Geographic region, stroke risk and renal function strongly affect treatment choice for stroke prevention in patients with non-valvular AF: results from the GLORIA-AF registry program
Beier, L, Franca, L R, Lip, G Y H, Huisman, M V, Zint, K, Halperin, J L, Diener, H.-C, Dubner, S J, Ma, C.-S, Teutsch, C, Paquette, M, Minkenberg, R, Lu, S, Rothman, K J
Published in European heart journal (01.08.2018)
Published in European heart journal (01.08.2018)
Get full text
Journal Article
P2887Two-year outcomes of dabigatran etexilate treatment in patients with co-morbid heart failure and atrial fibrillation: the GLORIA-AF registry
Dubner, S J, Huisman, M V, Diener, H C, Halperin, J L, Rothman, K J, Ma, C S, Bergler-Klein, J, Zint, K, Riou Franca, L, Lu, S, Teutsch, C, Paquette, M, Lip, G Y H
Published in European heart journal (01.08.2018)
Published in European heart journal (01.08.2018)
Get full text
Journal Article
200Safety of uninterrupted dabigatran in cardiovascular interventions in the GLORIA-AF registry program
Lip, GYH, Van Der Wall, S J, Teutsch, C, Rothman, K J, Diener, H-C, Dubner, S J, Ma, C S, Paquette, M, Lu, S, Riou Franca, L, Zint, K, Halperin, J L, Huisman, M V
Published in Europace (London, England) (01.03.2018)
Published in Europace (London, England) (01.03.2018)
Get full text
Journal Article
P281Baseline characteristics of patients with atrial fibrillation with and without comorbid heart failure: the GLORIA-AF registry
Dubner, SJ, Huisman, MV, Diener, H-C, Halperin, J., Rothman, KJ, Ma, C-S, Zint, K., Riou Franca, L., Lu, S., Teutsch, C., Paquette, M., Lip, GYH
Published in Europace (London, England) (01.06.2017)
Published in Europace (London, England) (01.06.2017)
Get full text
Journal Article